Overview

Efficacy of Topical Apraclonidine for the Treatment of Ocular Synkinesis

Status:
Not yet recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine efficacy of apraclonidine for patients with ocular synkinesis, who are seen in the UAB Facial Nerve Clinic.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Apraclonidine